[{"start_date": "2025-07-01", "end_date": "2025-09-30", "filing_date": "2025-11-04", "acceptance_datetime": "2025-11-04T21:05:58Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2025", "cik": "0001845337", "sic": "2834", "tickers": ["DAWN"], "company_name": "Day One Biopharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-25-264649", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-25-264649/files/dawn-20250930_htm.xml", "financials": {"balance_sheet": {"liabilities_and_equity": {"value": 513780000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_liabilities": {"value": 6446000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities": {"value": 62912000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_current_assets": {"value": 466213000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "equity": {"value": 450868000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_assets": {"value": 489971000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "current_liabilities": {"value": 56466000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_current_liabilities": {"value": 50688000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "fixed_assets": {"value": 2227000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "noncurrent_assets": {"value": 23809000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "inventory": {"value": 7061000.0, "unit": "USD", "label": "Inventory", "order": 230}, "other_noncurrent_assets": {"value": 21582000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "assets": {"value": 513780000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_parent": {"value": 450868000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "accounts_payable": {"value": 5778000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "accounts_receivable": {"value": 16697000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": -19565000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -19565000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -19565000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": 13460000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities": {"value": 0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": 7655000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -5805000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": 7655000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -5805000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": 13460000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}, "income_statement": {"diluted_earnings_per_share": {"value": -0.19, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_parent": {"value": -19726000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -19726000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "basic_average_shares": {"value": 103381315.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "research_and_development": {"value": 31419000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "other_operating_expenses": {"value": 32627000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "nonoperating_income_loss": {"value": 4525000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "diluted_average_shares": {"value": 103381315.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "operating_income_loss": {"value": -24251000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 19726000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "costs_and_expenses": {"value": 64046000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "operating_expenses": {"value": 64046000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "basic_earnings_per_share": {"value": -0.19, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "revenues": {"value": 39795000.0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_after_tax": {"value": 39795000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss": {"value": 0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "income_loss_from_continuing_operations_before_tax": {"value": 39795000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}}}}, {"start_date": "2025-04-01", "end_date": "2025-06-30", "filing_date": "2025-08-05", "acceptance_datetime": "2025-08-05T20:06:25Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2025", "cik": "0001845337", "sic": "2834", "tickers": ["DAWN"], "company_name": "Day One Biopharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-25-103012", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-25-103012/files/dawn-20250630_htm.xml", "financials": {"income_statement": {"benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "operating_income_loss": {"value": -34974000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_expenses": {"value": 68882000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "revenues": {"value": 33908000.0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_attributable_to_parent": {"value": -30322000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "research_and_development": {"value": 36149000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_before_tax": {"value": -30322000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "income_loss_from_continuing_operations_after_tax": {"value": -30322000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "basic_earnings_per_share": {"value": -0.29, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "diluted_average_shares": {"value": 103069154.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss": {"value": -30322000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "costs_and_expenses": {"value": 68882000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 30322000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "basic_average_shares": {"value": 103069154.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "diluted_earnings_per_share": {"value": -0.29, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "nonoperating_income_loss": {"value": 4652000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "other_operating_expenses": {"value": 32733000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_available_to_common_stockholders_basic": {"value": -30322000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": -90862000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -24806000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities": {"value": 26322000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -24806000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": -89346000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": 26322000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow": {"value": -89346000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": -90862000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -30362000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -30322000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "balance_sheet": {"noncurrent_assets": {"value": 24609000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity": {"value": 460834000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_parent": {"value": 460834000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_assets": {"value": 494428000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_noncurrent_assets": {"value": 22292000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "accounts_payable": {"value": 5090000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_current_liabilities": {"value": 46131000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities_and_equity": {"value": 519037000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "fixed_assets": {"value": 2317000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_current_assets": {"value": 468216000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "liabilities": {"value": 58203000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "assets": {"value": 519037000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_liabilities": {"value": 51221000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "inventory": {"value": 6543000.0, "unit": "USD", "label": "Inventory", "order": 230}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "accounts_receivable": {"value": 19669000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}}}}, {"start_date": "2025-01-01", "end_date": "2025-03-31", "filing_date": "2025-05-06", "acceptance_datetime": "2025-05-06T20:05:34Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2025", "cik": "0001845337", "sic": "2834", "tickers": ["DAWN"], "company_name": "Day One Biopharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-25-064436", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-25-064436/files/dawn-20250331_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -35996000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -36132000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": -32613000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 91610000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 91610000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": 0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -58997000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": -32613000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": 0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -58997000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}, "balance_sheet": {"accounts_payable": {"value": 2540000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "current_assets": {"value": 508651000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities": {"value": 54844000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_liabilities": {"value": 47879000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities_and_equity": {"value": 534356000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_current_assets": {"value": 487032000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "equity_attributable_to_parent": {"value": 479512000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "accounts_receivable": {"value": 18054000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "other_noncurrent_assets": {"value": 23197000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_current_liabilities": {"value": 45339000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity": {"value": 479512000.0, "unit": "USD", "label": "Equity", "order": 1400}, "fixed_assets": {"value": 2508000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "noncurrent_assets": {"value": 25705000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "inventory": {"value": 3565000.0, "unit": "USD", "label": "Inventory", "order": 230}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "assets": {"value": 534356000.0, "unit": "USD", "label": "Assets", "order": 100}}, "income_statement": {"other_operating_expenses": {"value": 32209000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "research_and_development": {"value": 39619000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_available_to_common_stockholders_basic": {"value": -35996000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_expenses": {"value": 71828000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "basic_average_shares": {"value": 102710382.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss_attributable_to_parent": {"value": -35996000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "basic_earnings_per_share": {"value": -0.35, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_loss_from_continuing_operations_after_tax": {"value": -35996000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "costs_and_expenses": {"value": 71828000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "diluted_average_shares": {"value": 102710382.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss": {"value": -35996000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "diluted_earnings_per_share": {"value": -0.35, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 35996000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "revenues": {"value": 30761000.0, "unit": "USD", "label": "Revenues", "order": 100}, "nonoperating_income_loss": {"value": 5071000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "operating_income_loss": {"value": -41067000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "income_loss_from_continuing_operations_before_tax": {"value": -35996000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}}}}, {"start_date": "2024-10-01", "end_date": "2024-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2024", "cik": "0001845337", "sic": "2834", "tickers": ["DAWN"], "company_name": "Day One Biopharmaceuticals, Inc.", "financials": {"income_statement": {"operating_income_loss": {"value": -65332000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_before_tax": {"value": 29208000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "basic_earnings_per_share": {"value": -0.69, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_tax_expense_benefit": {"value": 6474000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "basic_average_shares": {"value": 3069300.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss": {"value": -6474000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 59240000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -65714000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_expenses": {"value": 94540000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_after_tax": {"value": -6474000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "revenues": {"value": 29208000.0, "unit": "USD", "label": "Revenues", "order": 100}, "diluted_earnings_per_share": {"value": -0.69, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "costs_and_expenses": {"value": 94540000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "research_and_development": {"value": 61823000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "nonoperating_income_loss": {"value": 6092000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "other_operating_expenses": {"value": 32717000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_parent": {"value": -65714000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "diluted_average_shares": {"value": 3069300.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": -65624000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -65624000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -65624000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": -269640000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -30008000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities": {"value": 1851000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": -297797000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": -297797000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities_continuing": {"value": -30008000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities_continuing": {"value": 1851000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": -269640000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}, "balance_sheet": {"liabilities": {"value": 80037000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "fixed_assets": {"value": 2285000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity_attributable_to_parent": {"value": 502751000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": 73451000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity": {"value": 502751000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_assets": {"value": 20458000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "inventory": {"value": 3321000.0, "unit": "USD", "label": "Inventory", "order": 230}, "accounts_payable": {"value": 3262000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "current_assets": {"value": 562330000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_current_assets": {"value": 545133000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "liabilities_and_equity": {"value": 582788000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_current_liabilities": {"value": 70189000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_liabilities": {"value": 6586000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "accounts_receivable": {"value": 13876000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "other_noncurrent_assets": {"value": 18173000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "assets": {"value": 582788000.0, "unit": "USD", "label": "Assets", "order": 100}}}}, {"start_date": "2024-07-01", "end_date": "2024-09-30", "filing_date": "2024-10-30", "acceptance_datetime": "2024-10-30T20:05:26Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2024", "cik": "0001845337", "sic": "2834", "tickers": ["DAWN"], "company_name": "Day One Biopharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-24-118958", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-24-118958/files/dawn-20240930_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 37053000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": 37053000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": 37053000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "cash_flow_statement": {"net_cash_flow": {"value": 183149000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": 183149000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": -67699000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": 50753000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": -67699000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 200095000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": 50753000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 200095000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}, "balance_sheet": {"accounts_receivable": {"value": 8695000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "current_liabilities": {"value": 39745000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "assets": {"value": 600807000.0, "unit": "USD", "label": "Assets", "order": 100}, "accounts_payable": {"value": 3017000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_assets": {"value": 19811000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities": {"value": 45344000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "fixed_assets": {"value": 904000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "noncurrent_liabilities": {"value": 5599000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_assets": {"value": 580996000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities_and_equity": {"value": 600807000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_current_liabilities": {"value": 36728000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": 555463000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_noncurrent_assets": {"value": 18907000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "inventory": {"value": 2735000.0, "unit": "USD", "label": "Inventory", "order": 230}, "other_current_assets": {"value": 569566000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "equity": {"value": 555463000.0, "unit": "USD", "label": "Equity", "order": 1400}}, "income_statement": {"operating_expenses": {"value": 64125000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_available_to_common_stockholders_basic": {"value": 37037000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss": {"value": 882000, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": -36155000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "diluted_earnings_per_share": {"value": 0.38, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "basic_earnings_per_share": {"value": 0.38, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "costs_and_expenses": {"value": 64125000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_loss_from_continuing_operations_before_tax": {"value": 93761000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "basic_average_shares": {"value": 96623123.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "income_loss_from_continuing_operations_after_tax": {"value": 882000, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_parent": {"value": 37037000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_tax_expense_benefit_deferred": {"value": 900000, "unit": "USD", "label": "Income Tax Expense/Benefit, Deferred", "order": 2400}, "operating_income_loss": {"value": 29636000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "revenues": {"value": 93761000.0, "unit": "USD", "label": "Revenues", "order": 100}, "nonoperating_income_loss": {"value": 6519000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "income_tax_expense_benefit": {"value": -882000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "other_operating_expenses": {"value": 30562000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "research_and_development": {"value": 33563000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "diluted_average_shares": {"value": 96937759.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}}}}, {"start_date": "2024-04-01", "end_date": "2024-06-30", "filing_date": "2024-08-02", "acceptance_datetime": "2024-08-02T20:05:28Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2024", "cik": "0001845337", "sic": "2834", "tickers": ["DAWN"], "company_name": "Day One Biopharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-24-089945", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-24-089945/files/dawn-20240630_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": 17057000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -49129000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": 17057000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": -30775000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 1297000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": -30775000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 1297000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -49129000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -4424000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -4407000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "balance_sheet": {"other_noncurrent_assets": {"value": 17083000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_assets": {"value": 383158000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "inventory": {"value": 151000, "unit": "USD", "label": "Inventory", "order": 230}, "liabilities_and_equity": {"value": 400437000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "accounts_payable": {"value": 6444000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "current_liabilities": {"value": 93706000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_current_assets": {"value": 373871000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_current_liabilities": {"value": 87262000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities": {"value": 93706000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "accounts_receivable": {"value": 9136000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "equity": {"value": 306731000.0, "unit": "USD", "label": "Equity", "order": 1400}, "fixed_assets": {"value": 196000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "assets": {"value": 400437000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_parent": {"value": 306731000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_assets": {"value": 17279000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}}, "income_statement": {"diluted_earnings_per_share": {"value": -0.05, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "basic_average_shares": {"value": 87121310.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "diluted_average_shares": {"value": 87121310.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "basic_earnings_per_share": {"value": -0.05, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_loss_from_continuing_operations_before_tax": {"value": -4407000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "costs_and_expenses": {"value": 122999000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "benefits_costs_expenses": {"value": 122999000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 2855000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_tax_expense_benefit": {"value": 1552000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "income_loss_from_continuing_operations_after_tax": {"value": -4407000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss": {"value": -4407000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "revenues": {"value": 8192000.0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_attributable_to_parent": {"value": -4407000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -4407000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_expenses": {"value": 122999000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "other_operating_expenses": {"value": 30893000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "research_and_development": {"value": 92106000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "operating_income_loss": {"value": -114807000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "nonoperating_income_loss": {"value": 111952000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}}}}, {"start_date": "2024-01-01", "end_date": "2024-03-31", "filing_date": "2024-05-06", "acceptance_datetime": "2024-05-06T20:35:33Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2024", "cik": "0001845337", "sic": "2834", "tickers": ["DAWN"], "company_name": "Day One Biopharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-24-053612", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-24-053612/files/dawn-20240331_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -62412000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -62426000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "income_statement": {"diluted_earnings_per_share": {"value": -0.72, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "nonoperating_income_loss": {"value": 4355000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_after_tax": {"value": -62412000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss": {"value": -62412000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "basic_average_shares": {"value": 86679282.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "basic_earnings_per_share": {"value": -0.72, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "operating_expenses": {"value": 66767000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "other_operating_expenses": {"value": 26557000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "diluted_average_shares": {"value": 86679282.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_attributable_to_parent": {"value": -62412000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "costs_and_expenses": {"value": 66767000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_available_to_common_stockholders_basic": {"value": -62412000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "benefits_costs_expenses": {"value": 66767000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "income_loss_from_continuing_operations_before_tax": {"value": -62412000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "research_and_development": {"value": 40210000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "operating_income_loss": {"value": -66767000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}}, "balance_sheet": {"other_noncurrent_assets": {"value": 426000, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_parent": {"value": 296806000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "fixed_assets": {"value": 185000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "liabilities_and_equity": {"value": 326645000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_current_liabilities": {"value": 25059000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_assets": {"value": 611000, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "assets": {"value": 326645000.0, "unit": "USD", "label": "Assets", "order": 100}, "accounts_payable": {"value": 4780000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity": {"value": 296806000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_liabilities": {"value": 29839000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities": {"value": 29839000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_assets": {"value": 326034000.0, "unit": "USD", "label": "Current Assets", "order": 200}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -49729000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities_continuing": {"value": 48000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 48000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": 39607000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": 39607000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -49729000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": 89288000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": 89288000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}}}, {"start_date": "2023-10-01", "end_date": "2023-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2023", "cik": "0001845337", "sic": "2834", "tickers": ["DAWN"], "company_name": "Day One Biopharmaceuticals, Inc.", "financials": {"balance_sheet": {"other_noncurrent_assets": {"value": 566000, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity_attributable_to_parent": {"value": 346540000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_assets": {"value": 774000, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "assets": {"value": 376048000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities": {"value": 29508000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_current_liabilities": {"value": 26932000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities_and_equity": {"value": 376048000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_liabilities": {"value": 29508000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity": {"value": 346540000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_assets": {"value": 375274000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "fixed_assets": {"value": 208000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "accounts_payable": {"value": 2576000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -54495000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -54495000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 16000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "cash_flow_statement": {"net_cash_flow": {"value": -10395000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -41372000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": 30380000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": 597000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": 30380000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 597000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -41372000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": -10395000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}, "income_statement": {"basic_average_shares": {"value": 2090767.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss_available_to_common_stockholders_basic": {"value": -54511000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "research_and_development": {"value": 37348000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "operating_expenses": {"value": 59517000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "operating_income_loss": {"value": -59517000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_after_tax": {"value": -54511000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "diluted_earnings_per_share": {"value": -0.6400000000000001, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "basic_earnings_per_share": {"value": -0.6400000000000001, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "diluted_average_shares": {"value": 2090767.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_before_tax": {"value": -54511000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "other_operating_expenses": {"value": 22169000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_parent": {"value": -54511000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss": {"value": -54511000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}}}}, {"start_date": "2023-07-01", "end_date": "2023-09-30", "filing_date": "2023-11-06", "acceptance_datetime": "2023-11-06T21:48:50Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2023", "cik": "0001845337", "sic": "2834", "tickers": ["DAWN"], "company_name": "Day One Biopharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-23-059485", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-23-059485/files/dawn-20230930_htm.xml", "financials": {"comprehensive_income": {"other_comprehensive_income_loss": {"value": 2000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -46148000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -46148000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": 88917000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -37064000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities_continuing": {"value": 115000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 115000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": 51968000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -37064000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": 51968000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": 88917000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}, "income_statement": {"basic_earnings_per_share": {"value": -0.54, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_before_tax": {"value": -46150000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_expenses": {"value": 51438000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "diluted_average_shares": {"value": 85952501.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_attributable_to_parent": {"value": -46150000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -46150000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "other_operating_expenses": {"value": 18275000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "diluted_earnings_per_share": {"value": -0.54, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "research_and_development": {"value": 33163000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_after_tax": {"value": -46150000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "basic_average_shares": {"value": 85952501.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "operating_income_loss": {"value": -51438000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss": {"value": -46150000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}}, "balance_sheet": {"liabilities": {"value": 24552000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_liabilities": {"value": 77000, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "noncurrent_assets": {"value": 888000, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_noncurrent_assets": {"value": 675000, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "fixed_assets": {"value": 213000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_assets": {"value": 413291000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "accounts_payable": {"value": 3391000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities_and_equity": {"value": 414179000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity": {"value": 389627000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_parent": {"value": 389627000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": 24475000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "assets": {"value": 414179000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_current_liabilities": {"value": 21084000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}}}}, {"start_date": "2023-04-01", "end_date": "2023-06-30", "filing_date": "2023-08-07", "acceptance_datetime": "2023-08-07T20:36:18Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2023", "cik": "0001845337", "sic": "2834", "tickers": ["DAWN"], "company_name": "Day One Biopharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-23-039118", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-23-039118/files/dawn-20230630_htm.xml", "financials": {"income_statement": {"net_income_loss_attributable_to_parent": {"value": -45863000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "diluted_earnings_per_share": {"value": -0.61, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -45863000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_before_tax": {"value": -45863000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "research_and_development": {"value": 32182000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "diluted_average_shares": {"value": 74964878.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "operating_expenses": {"value": 49254000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "other_operating_expenses": {"value": 17072000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_loss_from_continuing_operations_after_tax": {"value": -45863000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss": {"value": -45863000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "basic_average_shares": {"value": 74964878.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "operating_income_loss": {"value": -49254000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "basic_earnings_per_share": {"value": -0.61, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}}, "balance_sheet": {"liabilities_and_equity": {"value": 450756000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_noncurrent_assets": {"value": 789000, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "fixed_assets": {"value": 183000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "liabilities": {"value": 24702000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_parent": {"value": 426054000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "assets": {"value": 450756000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_assets": {"value": 972000, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_current_liabilities": {"value": 19947000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "current_liabilities": {"value": 24512000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "accounts_payable": {"value": 4565000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "current_assets": {"value": 449784000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity": {"value": 426054000.0, "unit": "USD", "label": "Equity", "order": 1400}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -45939000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -45863000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 162101000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": 139943000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": 162101000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": 20274000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -42432000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -42432000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": 139943000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": 20274000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}}}, {"start_date": "2023-01-01", "end_date": "2023-03-31", "filing_date": "2023-05-01", "acceptance_datetime": "2023-05-01T13:08:05Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2023", "cik": "0001845337", "sic": "2834", "tickers": ["DAWN"], "company_name": "Day One Biopharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-23-016046", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-23-016046/files/dawn-20230331_htm.xml", "financials": {"income_statement": {"net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "other_operating_expenses": {"value": 18027000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_loss_from_continuing_operations_after_tax": {"value": -42393000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "basic_average_shares": {"value": 71972888.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "operating_expenses": {"value": 45855000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "diluted_average_shares": {"value": 71972888.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "operating_income_loss": {"value": -45855000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_available_to_common_stockholders_basic": {"value": -42393000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss": {"value": -42393000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "basic_earnings_per_share": {"value": -0.59, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_loss_from_continuing_operations_before_tax": {"value": -42393000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "research_and_development": {"value": 27828000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_attributable_to_parent": {"value": -42393000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "diluted_earnings_per_share": {"value": -0.59, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}}, "balance_sheet": {"equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": 300415000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities": {"value": 23148000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_assets": {"value": 323563000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities_and_equity": {"value": 323563000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_liabilities": {"value": 22848000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_assets": {"value": 0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_current_liabilities": {"value": 18191000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity": {"value": 300415000.0, "unit": "USD", "label": "Equity", "order": 1400}, "assets": {"value": 323563000.0, "unit": "USD", "label": "Assets", "order": 100}, "accounts_payable": {"value": 4657000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "fixed_assets": {"value": 72000, "unit": "USD", "label": "Fixed Assets", "order": 320}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -42393000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -42255000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": -11193000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -25985000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": -25985000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": -11193000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": -35994000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": 1184000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 1184000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": -35994000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}}}, {"start_date": "2022-10-01", "end_date": "2022-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2022", "cik": "0001845337", "sic": "2834", "tickers": ["DAWN"], "company_name": "Day One Biopharmaceuticals, Inc.", "financials": {"comprehensive_income": {"other_comprehensive_income_loss": {"value": 321000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -39788000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -39788000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "balance_sheet": {"assets": {"value": 349062000.0, "unit": "USD", "label": "Assets", "order": 100}, "accounts_payable": {"value": 260000, "unit": "USD", "label": "Accounts Payable", "order": 710}, "fixed_assets": {"value": 20000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity": {"value": 332039000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities": {"value": 17023000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_noncurrent_assets": {"value": 1168000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_assets": {"value": 347874000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "current_liabilities": {"value": 16615000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_parent": {"value": 332039000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities_and_equity": {"value": 349062000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_liabilities": {"value": 408000, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "noncurrent_assets": {"value": 1188000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_current_liabilities": {"value": 16355000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}}, "income_statement": {"costs_and_expenses": {"value": 42769000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "diluted_average_shares": {"value": 1943999.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "interest_income_expense_operating_net": {"value": 2660000.0, "unit": "USD", "label": "Interest Income/Expense Operating, Net", "order": 2900}, "revenues": {"value": 2660000.0, "unit": "USD", "label": "Revenues", "order": 100}, "research_and_development": {"value": 26020000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "basic_average_shares": {"value": 1943999.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "operating_income_loss": {"value": -42743000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "provision_for_loan_lease_and_other_losses": {"value": 0, "unit": "USD", "label": "Provision For Loan, Lease, And Other Losses", "order": 4000}, "interest_income_expense_after_provision_for_losses": {"value": 2660000.0, "unit": "USD", "label": "Interest Income/Expense After Provision For Losses", "order": 2800}, "net_income_loss_attributable_to_parent": {"value": -40109000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -40109000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "benefits_costs_expenses": {"value": 42769000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "diluted_earnings_per_share": {"value": -0.5599999999999998, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_expenses": {"value": 42743000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_after_tax": {"value": -40109000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "income_loss_from_continuing_operations_before_tax": {"value": -40109000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "basic_earnings_per_share": {"value": -0.5599999999999998, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss_attributable_to_redeemable_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Redeemable Noncontrolling Interest", "order": 3600}, "net_income_loss": {"value": -40109000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "other_operating_expenses": {"value": 16723000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": -2210000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -35310000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 1918000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -35310000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 1918000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": -35602000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": -35602000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": -2210000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}}}, {"start_date": "2022-07-01", "end_date": "2022-09-30", "filing_date": "2022-11-07", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2022", "cik": "0001845337", "sic": "2834", "tickers": ["DAWN"], "company_name": "Day One Biopharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-22-022667", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-22-022667/files/dawn-20220930_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow": {"value": -268013000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -23214000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities": {"value": 2053000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": -268013000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": 2053000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": -246852000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": -246852000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -23214000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -38184000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -38184000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -389000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "balance_sheet": {"noncurrent_liabilities": {"value": 514000, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "assets": {"value": 381861000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_parent": {"value": 363076000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_assets": {"value": 381861000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_assets": {"value": 0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity": {"value": 363076000.0, "unit": "USD", "label": "Equity", "order": 1400}, "fixed_assets": {"value": 35000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "accounts_payable": {"value": 3973000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities": {"value": 18785000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "liabilities_and_equity": {"value": 381861000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_liabilities": {"value": 18271000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_current_liabilities": {"value": 14298000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}}, "income_statement": {"diluted_average_shares": {"value": 71008993.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "provision_for_loan_lease_and_other_losses": {"value": 0, "unit": "USD", "label": "Provision For Loan, Lease, And Other Losses", "order": 4000}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "costs_and_expenses": {"value": 39690000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss": {"value": -37795000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_income_loss": {"value": -39699000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "other_operating_expenses": {"value": 17664000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_redeemable_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Redeemable Noncontrolling Interest", "order": 3600}, "income_loss_from_continuing_operations_before_tax": {"value": -37795000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "basic_average_shares": {"value": 71008993.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "benefits_costs_expenses": {"value": 39690000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "interest_income_expense_after_provision_for_losses": {"value": 1895000.0, "unit": "USD", "label": "Interest Income/Expense After Provision For Losses", "order": 2800}, "net_income_loss_attributable_to_parent": {"value": -37795000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "basic_earnings_per_share": {"value": -0.53, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "interest_income_expense_operating_net": {"value": 1895000.0, "unit": "USD", "label": "Interest Income/Expense Operating, Net", "order": 2900}, "operating_expenses": {"value": 39699000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "research_and_development": {"value": 22035000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_available_to_common_stockholders_basic": {"value": -37795000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_after_tax": {"value": -37795000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "revenues": {"value": 1895000.0, "unit": "USD", "label": "Revenues", "order": 100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "diluted_earnings_per_share": {"value": -0.53, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}}}}, {"start_date": "2022-04-01", "end_date": "2022-06-30", "filing_date": "2022-08-04", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2022", "cik": "0001845337", "sic": "2834", "tickers": ["DAWN"], "company_name": "Day One Biopharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-22-014859", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-22-014859/files/dawn-20220630_htm.xml", "financials": {"income_statement": {"research_and_development": {"value": 22560000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "benefits_costs_expenses": {"value": 36719000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "interest_income_expense_after_provision_for_losses": {"value": 189000, "unit": "USD", "label": "Interest Income/Expense After Provision For Losses", "order": 2800}, "costs_and_expenses": {"value": 36719000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "basic_earnings_per_share": {"value": -0.6, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss_attributable_to_parent": {"value": -36530000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "diluted_earnings_per_share": {"value": -0.6, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -36530000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "interest_income_expense_operating_net": {"value": 189000, "unit": "USD", "label": "Interest Income/Expense Operating, Net", "order": 2900}, "income_loss_from_continuing_operations_before_tax": {"value": -36530000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "diluted_average_shares": {"value": 60760527.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "revenues": {"value": 189000, "unit": "USD", "label": "Revenues", "order": 100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_income_loss": {"value": -36719000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "operating_expenses": {"value": 36719000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "other_operating_expenses": {"value": 14159000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "provision_for_loan_lease_and_other_losses": {"value": 0, "unit": "USD", "label": "Provision For Loan, Lease, And Other Losses", "order": 4000}, "basic_average_shares": {"value": 60760527.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss": {"value": -36530000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_loss_from_continuing_operations_after_tax": {"value": -36530000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_redeemable_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Redeemable Noncontrolling Interest", "order": 3600}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -36533000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -36530000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "balance_sheet": {"current_assets": {"value": 404047000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_assets": {"value": 0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "fixed_assets": {"value": 67000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "accounts_payable": {"value": 439000, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities": {"value": 13416000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_parent": {"value": 390631000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities_and_equity": {"value": 404047000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_current_liabilities": {"value": 12360000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity": {"value": 390631000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_liabilities": {"value": 12799000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "assets": {"value": 404047000.0, "unit": "USD", "label": "Assets", "order": 100}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -29787000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": 126146000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": -5997000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -29787000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": -5997000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": 126146000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}}}, {"start_date": "2022-01-01", "end_date": "2022-03-31", "filing_date": "2022-05-12", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2022", "cik": "0001845337", "sic": "2834", "tickers": ["DAWN"], "company_name": "Day One Biopharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-22-009734", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-22-009734/files/dawn-20220331_htm.xml", "financials": {"comprehensive_income": {"other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -27747000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -27747000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "income_statement": {"revenues": {"value": 2000, "unit": "USD", "label": "Revenues", "order": 100}, "other_operating_expenses": {"value": 12745000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "benefits_costs_expenses": {"value": 27749000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_attributable_to_parent": {"value": -27747000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_income_loss": {"value": -27748000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_expenses": {"value": 27748000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "provision_for_loan_lease_and_other_losses": {"value": 0, "unit": "USD", "label": "Provision For Loan, Lease, And Other Losses", "order": 4000}, "diluted_earnings_per_share": {"value": -0.4800000000000001, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "income_loss_from_continuing_operations_before_tax": {"value": -27747000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss": {"value": -27747000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_redeemable_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Redeemable Noncontrolling Interest", "order": 3600}, "basic_earnings_per_share": {"value": -0.4800000000000001, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "diluted_average_shares": {"value": -1173998.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "income_loss_from_continuing_operations_after_tax": {"value": -27747000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_available_to_common_stockholders_basic": {"value": -27747000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "basic_average_shares": {"value": -1173998.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "interest_income_expense_operating_net": {"value": 2000, "unit": "USD", "label": "Interest Income/Expense Operating, Net", "order": 2900}, "research_and_development": {"value": 15003000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "costs_and_expenses": {"value": 27749000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "interest_income_expense_after_provision_for_losses": {"value": 2000, "unit": "USD", "label": "Interest Income/Expense After Provision For Losses", "order": 2800}}, "balance_sheet": {"current_assets": {"value": 267779000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity": {"value": 259603000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_assets": {"value": 0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "fixed_assets": {"value": 66000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "assets": {"value": 267779000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_liabilities": {"value": 8176000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_parent": {"value": 259603000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities_and_equity": {"value": 267779000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "accounts_payable": {"value": 701000, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities": {"value": 8176000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_current_liabilities": {"value": 7475000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}}, "cash_flow_statement": {"net_cash_flow_continuing": {"value": -21578000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -21563000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": -21578000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": -15000, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -21563000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities": {"value": -15000, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}}}, {"start_date": "2021-10-01", "end_date": "2021-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2021", "cik": "0001845337", "sic": "2834", "tickers": ["DAWN"], "company_name": "Day One Biopharmaceuticals, Inc.", "financials": {"balance_sheet": {"liabilities_and_equity": {"value": 289821000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "liabilities": {"value": 8673000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_assets": {"value": 289368000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_current_liabilities": {"value": 6913000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_liabilities": {"value": 8657000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "accounts_payable": {"value": 1744000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_noncurrent_assets": {"value": 396000, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "assets": {"value": 289821000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_assets": {"value": 453000, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_parent": {"value": 281148000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity": {"value": 281148000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_liabilities": {"value": 16000, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "fixed_assets": {"value": 57000, "unit": "USD", "label": "Fixed Assets", "order": 320}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": 0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": 318000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_financing_activities_continuing": {"value": 318000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": -12851000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": -12851000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": 0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -13169000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": -13169000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}, "income_statement": {"net_income_loss_available_to_common_stockholders_basic": {"value": -17720000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_expenses": {"value": 21975000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_parent": {"value": -17720000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "research_and_development": {"value": 11189000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_before_tax": {"value": -21938000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss": {"value": -21938000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "revenues": {"value": 4000, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": -4218000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "operating_income_loss": {"value": -21975000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_after_tax": {"value": -21938000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "other_operating_expenses": {"value": 10786000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -21938000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -21938000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}}}, {"start_date": "2021-07-01", "end_date": "2021-09-30", "filing_date": "2021-11-08", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2021", "cik": "0001845337", "sic": "2834", "tickers": ["DAWN"], "company_name": "Day One Biopharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-21-003496", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-21-003496/files/dawn-20210930_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow": {"value": -12836000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": -615000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": 0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -12221000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": -12836000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": -615000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": -12221000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": 0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}, "balance_sheet": {"noncurrent_assets": {"value": 0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity": {"value": 297672000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_liabilities": {"value": 65000, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_current_liabilities": {"value": 5363000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "fixed_assets": {"value": 62000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "liabilities_and_equity": {"value": 303783000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_parent": {"value": 297672000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "assets": {"value": 303783000.0, "unit": "USD", "label": "Assets", "order": 100}, "accounts_payable": {"value": 683000, "unit": "USD", "label": "Accounts Payable", "order": 710}, "current_assets": {"value": 303783000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities": {"value": 6111000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_liabilities": {"value": 6046000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}}, "income_statement": {"research_and_development": {"value": 9849000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_before_tax": {"value": -19240000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "interest_expense_operating": {"value": 6000, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "operating_income_loss": {"value": -19241000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_after_tax": {"value": -19240000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss": {"value": -19240000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_parent": {"value": -19240000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_available_to_common_stockholders_basic": {"value": -19240000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_expenses": {"value": 19241000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "other_operating_expenses": {"value": 9392000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -19240000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -19240000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}}}, {"start_date": "2021-04-01", "end_date": "2021-06-30", "filing_date": "2021-08-10", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2021", "cik": "0001845337", "sic": "2834", "tickers": ["DAWN"], "company_name": "Day One Biopharmaceuticals, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-21-242039", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-21-242039/files/d180355d10q_htm.xml", "financials": {"income_statement": {"research_and_development": {"value": 9914000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss": {"value": -15473000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_attributable_to_parent": {"value": -14284000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "other_operating_expenses": {"value": 5525000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_loss_from_continuing_operations_before_tax": {"value": -14284000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_expenses": {"value": 15439000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "interest_expense_operating": {"value": 7000, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "operating_income_loss": {"value": -15439000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_redeemable_noncontrolling_interest": {"value": 1191000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Redeemable Noncontrolling Interest", "order": 3600}, "income_loss_from_continuing_operations_after_tax": {"value": -14284000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 1191000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -14284000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}}, "balance_sheet": {"noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "assets": {"value": 316537000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities_and_equity": {"value": 316537000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity": {"value": 311763000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_liabilities": {"value": 4662000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_current_liabilities": {"value": 4314000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "accounts_payable": {"value": 348000, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities": {"value": 4774000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_parent": {"value": 311763000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_assets": {"value": 0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "fixed_assets": {"value": 67000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "current_assets": {"value": 316537000.0, "unit": "USD", "label": "Current Assets", "order": 200}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -14284000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -14284000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}}}, {"start_date": "2021-01-01", "end_date": "2021-03-30", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2021", "cik": "0001845337", "sic": "2834", "tickers": ["DAWN"], "company_name": "Day One Biopharmaceuticals, Inc.", "financials": {"balance_sheet": {"noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_parent": {"value": -68849000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity": {"value": -68849000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities": {"value": 68849000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_liabilities": {"value": 68849000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}}, "income_statement": {"net_income_loss": {"value": -15182000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_expenses": {"value": 16088000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_available_to_common_stockholders_basic": {"value": -15182000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_after_tax": {"value": -15182000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "operating_income_loss": {"value": -16088000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "other_operating_expenses": {"value": 3456000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_parent": {"value": -15182000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_attributable_to_redeemable_noncontrolling_interest": {"value": 918000, "unit": "USD", "label": "Net Income/Loss Attributable To Redeemable Noncontrolling Interest", "order": 3600}, "interest_expense_operating": {"value": 6000, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "income_loss_from_continuing_operations_before_tax": {"value": -15182000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "research_and_development": {"value": 12632000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -15182000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -15182000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}}}]